Spero Therapeutics, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $83.4M | $145.8M | $72.1M |
| Jun 2022 | $27.7M | $63.6M | $45.4M |
| Sep 2022 | $32.0M | $64.5M | $50.4M |
| Dec 2022 | $48.9M | $124.8M | $109.1M |
| Mar 2023 | $47.7M | $112.5M | $96.3M |
| Jun 2023 | $44.1M | $98.9M | $77.7M |
| Sep 2023 | $53.4M | $107.1M | $93.8M |
| Dec 2023 | $75.5M | $182.4M | $76.3M |
| Mar 2024 | $71.5M | $167.7M | $82.3M |
| Jun 2024 | $69.4M | $149.9M | $63.5M |
| Sep 2024 | $69.7M | $135.2M | $76.3M |
| Dec 2024 | $64.4M | $110.5M | $52.9M |
| Mar 2025 | $43.9M | $77.7M | $48.9M |
| Jun 2025 | $29.3M | $62.1M | $31.2M |
| Sep 2025 | $27.7M | $54.2M | $48.6M |
| Dec 2025 | $9.9M | $68.9M | $40.3M |
| Mar 2026 | $6.1M | $59.0M | $56.1M |
| Jun 2026 | $8.6M | $52.8M | $50.8M |